SMA |
ISIN | DE000A0DJ6J9 |
Security | SMA |
Exchange | EUREX |
Type | Option |
Options
Exp. date | Type | Type |
---|---|---|
4/21 | 56 Calls | 55 Puts |
5/21 | 35 Calls | 35 Puts |
6/21 | 54 Calls | 53 Puts |
9/21 | 28 Calls | 27 Puts |
12/21 | 31 Calls | 31 Puts |
3/22 | 18 Calls | 18 Puts |
6/22 | 18 Calls | 18 Puts |
12/22 | 21 Calls | 21 Puts |
6/23 | 16 Calls | 16 Puts |
12/23 | 19 Calls | 19 Puts |
12/24 | 17 Calls | 17 Puts |
12/25 | 11 Calls | 11 Puts |
Puts
Strike | Last | Open Interest | |
---|---|---|---|
30.00 | 0.41 | 14 | |
40.00 | 1.65 | 10 | |
44.00 | 2.57 | 10 | |
46.00 | 1.61 | 22 | |
49.00 | 4.10 | 22 | |
50.00 | 1.75 | 111 | |
60.00 | 13.25 | 1 |
News
- Leading Standards and Urban Forestry Partners Collaborate to Develop a New SFI Urban and Community Forest Sustainability Standard
04/01/2021 / 15:00 - GlobeNewswire - Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
02/26/2021 / 13:30 - GlobeNewswire - Equinor ASA: Correction: Information relating to proposed dividend for fourth quarter 2020
02/24/2021 / 07:51 - GlobeNewswire - 180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor
02/22/2021 / 22:05 - GlobeNewswire - Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated With Zolgensma® (onasemnogene abeparvovec)
01/08/2021 / 13:30 - GlobeNewswire